IP Verse

Process For The Manufacture Of Vortioxetine Hbr Alpha-Form

Patent No. EP3615518 (titled "Process For The Manufacture Of Vortioxetine Hbr Alpha-Form") was filed by H Lundbeck on Apr 20, 2018. The application was issued on Dec 15, 2021.

Patent Summary

A process for synthesizing a specific crystalline form of vortioxetine hydrobromide (α-form) used in pharmaceuticals. The process involves dissolving vortioxetine in highly pure toluene, followed by crystallization and drying steps. The resulting crystalline vortioxetine hydrobromide α-form can be used in pharmaceuticals to potentially improve factors like solubility and bioavailability.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKSep 15, 2022ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3615518

H LUNDBECK
Application Number
EP18721975A
Filing Date
Apr 20, 2018
Status
Granted And Under Opposition
Nov 12, 2021
Publication Date
Dec 15, 2021
External Links
Slate, Register , Google Patents